Indoco Remedies Limited has informed the Exchange regarding a press release dated August 21, 2024, titled "Indoco Remedies receives final ANDA approval from the USFDA for Lofexidine Tablets 0.18 mg with Competitive Generic Therapy designation".
Indoco Remedies Limited has informed the Exchange regarding a press release dated August 21, 2024, titled "Indoco Remedies receives final ANDA approval from the USFDA for Lofexidine Tablets 0.18 mg with Competitive Generic Therapy designation".